Compare SPDR Kensho Final Frontiers ETF (ROKT) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Kensho Final Frontiers ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? SPDR Kensho Final Frontiers ETF trades at $102.69 (market cap $170.14M), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.67 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 13.3× SPDR Kensho Final Frontiers ETF's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals.
| ROKT | SLS | |
|---|---|---|
Market Cap | $170.14M | $2.27B |
Volume | 12,298 | 4,179,659 |
Sector | Sector/Thematic | Health |
52-Week High | $136.68 | $15.46 |
52-Week Low | $72.93 | $1.39 |
Typical Hold Time | 8 Days | — |
Enterprise Value | — | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
